07.01.2020 • NewsBASFDede WillamsDuPont

BASF Ultrafiltration Membranes now with DuPont

BASF Ultrafiltration Membranes now with DuPont (c) BASF
BASF Ultrafiltration Membranes now with DuPont (c) BASF

Following all necessary approvals, BASF has completed the sale of its ultrafiltration membrane business to DuPont’s Safety & Construction division, as announced in September 2019.

The deal for which financial details were not disclosed, includes the business’s international workforce, headquarters and production site in Greifenberg, Germany, along with associated intellectual property.

BASF’s subsidiary Inge, which manufactures ultrafiltration membranes used in treating drinking water, process water, waste water and sea water, has also transferred to DuPont. The Ludwigshafen group acquired the business from a private equity investor in 2011.

While BASF said synergies between it and Inge were “very limited,” it noted that selling it to a strategic buyer such as DuPont would provide “strong value creation potential” for the business and enable it to reach the next level of growth.

With the acquisition, DuPont said it is strengthening its portfolio of water purification and separation technologies, including ultrafiltration, reverse osmosis and ion exchange resins.

“This technology in combination with Inge’s expert team further broadens our portfolio and enhances our ability to design tailored, integrated solutions for drinking water, industrial and waste water treatment applications globally,” Rose Lee, president of DuPont Safety & Construction, said at the time the deal was announced.

In another move to boost its water purification business, in mid- December DuPont signed an agreement to acquire Newton, Massachusetts-based Desalitech, a US closed circuit reverse osmosis (CCRO) company. The transaction is expected to close this month, subject to customary closing conditions and regulatory approvals.  Financial terms of this agreement were also not disclosed.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.